JFrog Ltd. (NASDAQ:FROG – Get Free Report) Director Elisa Steele sold 554 shares of the company’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $103.41, for a total transaction of $57,289.14. Following the completion of the sale, the director directly owned 23,750 shares of the company’s stock, valued at $2,455,987.50. This trade represents a 2.28% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
JFrog Stock Performance
Shares of FROG stock traded down $8.29 on Tuesday, hitting $91.78. 2,732,395 shares of the company’s stock traded hands, compared to its average volume of 2,937,411. JFrog Ltd. has a one year low of $34.05 and a one year high of $105.76. The company’s fifty day simple moving average is $88.49 and its 200 day simple moving average is $67.47. The stock has a market capitalization of $11.32 billion, a price-to-earnings ratio of -248.05 and a beta of 1.22.
JFrog (NASDAQ:FROG – Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.03. The business had revenue of $163.77 million during the quarter, compared to the consensus estimate of $155.63 million. JFrog had a negative net margin of 7.35% and a negative return on equity of 2.71%. The firm’s revenue for the quarter was up 28.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.18 earnings per share. JFrog has set its Q3 2026 guidance at 0.220-0.240 EPS and its FY 2026 guidance at 0.960-1.000 EPS. As a group, sell-side analysts anticipate that JFrog Ltd. will post -0.11 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Check Out Our Latest Stock Analysis on FROG
Hedge Funds Weigh In On JFrog
Hedge funds and other institutional investors have recently modified their holdings of the company. Royal Bank of Canada grew its stake in shares of JFrog by 48.4% in the first quarter. Royal Bank of Canada now owns 189,148 shares of the company’s stock worth $6,053,000 after purchasing an additional 61,685 shares during the last quarter. Cubist Systematic Strategies LLC bought a new position in JFrog during the 1st quarter valued at approximately $205,000. AQR Capital Management LLC purchased a new stake in JFrog in the 1st quarter worth approximately $368,000. Integrated Wealth Concepts LLC purchased a new stake in JFrog in the 1st quarter worth approximately $203,000. Finally, Goldman Sachs Group Inc. grew its position in shares of JFrog by 14.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 692,909 shares of the company’s stock worth $22,173,000 after buying an additional 88,784 shares during the last quarter. 85.02% of the stock is owned by institutional investors.
JFrog Company Profile
JFrog is a software company specializing in DevOps solutions designed to streamline the management, distribution and security of software binaries. Its core offering, JFrog Artifactory, serves as a universal artifact repository manager compatible with all major package formats, enabling development teams to store, version and share build artifacts across the software delivery pipeline. The company’s platform also includes tools for continuous integration and delivery (CI/CD), security scanning and release automation.
Among JFrog’s flagship products are JFrog Xray, a security and compliance scanning service that analyzes artifacts and dependencies for vulnerabilities; JFrog Pipelines, a CI/CD orchestration engine that automates build and release workflows; and JFrog Distribution, which accelerates the secure distribution of software releases to edge nodes and end users.
Recommended Stories
- Five stocks we like better than JFrog
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Receive News & Ratings for JFrog Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JFrog and related companies with MarketBeat.com's FREE daily email newsletter.
